Our analytical development laboratories have a strong staff structure consisting of qualified personnel, personnel skilled in different fields such as organic chemistry, analytical chemistry and biochemistry. The personnel have completed their graduate and doctorate education, are highly competent and have long years of R&D experience. Each member of staff constantly develops their capability to find accurate solutions in line with experience, innovative perspective and changing needs and following every new publication in detail in the meaning of research experience and quality. In this scope, academic studies are supported and the literature on the pharmaceutical and analytical development is contributed by publishing our studies in the journals with international index.

For the more than 50 countries we offer health services to, we follow the requirements of a number of pharmacopeias, such as the EP (European Pharmacopeia), the USP (United States Pharmacopeia) and the BP (British Pharmacopeia) which are internationally accepted with under the directives of the TİTCK (Turkish Medicine and Medical Devices Agency), the ICH (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), the FDA (United States Food and Drug Administration) and the EMA (European Medicines Agency), in a manner which complies with the principles of GLP (Good Laboratory Practices) with analytical requirements fulfilled under the regulation studies.

Know-how, which are acquired by our company by virtue of the worldwide regulation and the importance we attach to exports, has taken the knowledge and experience of our team to the highest levels. With the advancing of technology in recent years, only specifications such as the quantity of the active substance, the uniformity of the content, the checking of impurities arising from moisture, dissolution, active substances or auxiliary substances are not considered sufficient criteria in the presentation of the product quality of pharmaceuticals. National and international regulations, which we are party to us as required by our activities, require checks involving advanced analytic studies such as the identification of unknown impurities in the pharmaceuticals; genotoxic, carcinogenic, teratogenic checks and checks of impurities; check of extractables and leachable impurities, which may arise from the primary packaging materials or storage conditions during the stability; and determination of nitrosamine impurities, elemental impurity and heavy metal. We check the safety and quality of products in this unique laboratory which we established with our own analytical development staff without depending on external resources.

We conduct all of such studies with a number of specific devices in our analytical development laboratories, such as HPLC tracks with various detectors, including LC-Q/TOF, LC-MS/MS, GC-MS, ICP-MS, Transdermal / Franz Diffusion Cell System, electrochemical, fluorescence, gel permeability, conductivity, refractive index and photo-diodearray equipment.

Our Analytical Development department, which is affiliated with our R&D center, commands the position of being the best R&D laboratory in Eastern Europe on the basis of many parameters, such as the specialized staff, advanced laboratory and equipment and capability for advanced analytical study.